Skip to main content
Clinical Trials/NCT00218335
NCT00218335
Completed
Phase 2

A Network & Dyad HIV Prevention Intervention for IDU's

Johns Hopkins Bloomberg School of Public Health1 site in 1 country1,024 target enrollmentJune 2003
ConditionsHIVHepatitis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
HIV
Sponsor
Johns Hopkins Bloomberg School of Public Health
Enrollment
1024
Locations
1
Primary Endpoint
Any Sex Risk
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.

Detailed Description

HIV seroincidence among injection drug users remains high, with unprotected sexual contact substantially contributing to new HIV infections among injection drug users (IDUs). Interventions that are culturally competent and target drug users' main sex and drug partners may be especially effective for HIV/STI and HCV control and prevention. The intervention to be tested in this study draws upon theoretical and empirical evidence suggesting that peer educator programs can have significant effects on the risk-related behaviors of both the educators and the peers whom they educate. Specifically, through group and individual focused sessions, participants learn and practice skills designed to reduce drug and sex related risk behaviors. Furthermore, individuals and their main risk partners attend a training session that focuses on risk reduction within their relationship.

Registry
clinicaltrials.gov
Start Date
June 2003
End Date
May 2008
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Carl Latkin

Professor

Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria

Inclusion Criteria

  • (i)Self reported injection drug use within the prior 6 months; (ii)Willingness to invite a risk network member into the study and to talk about HIV prevention; (iii)Age 18 or older

Exclusion Criteria

  • Not concurrently enrolled in another HIV prevention intervention

Outcomes

Primary Outcomes

Any Sex Risk

Time Frame: 6 months

Talked About HIV-related Topics With Drug Buddies (in the Past Month)

Time Frame: 12 months

Showed a Needleless Syringe to Drug Buddies

Time Frame: 18 months

Talked About Responding to Overdose to Drug Buddies

Time Frame: 6 months

Any Injection Risk (Monthly Versus Never)

Time Frame: 18 months

Number of Needle or Cooker Sharers (2 or More Versus None)

Time Frame: 18 months

Shared Cooker When Preparing Drugs

Time Frame: 18 months

Injecting Drugs

Time Frame: 18 months

Talked About HIV-related Topics With Drug Buddies (in Past Month)

Time Frame: 18 months

Talked About Hepatitis to Drug Buddies

Time Frame: 18 months

Study Sites (1)

Loading locations...

Similar Trials